Waters Honors University of Minnesota's Joseph Dalluge and Department of Chemistry Mass Spectrometry Laboratory with Center of Innovation Recognition

Waters Corporation (Milford, Massachusetts) recently welcomed the University of Minnesota’s (Minneapolis, Minnesota) Mass Spectrometry Laboratory into its Centers of Innovation Program. Waters honored the Mass Spectrometry Laboratory under the direction of Joseph Dalluge for his research in diagnostic marker assay development relevant to cystic fibrosis and other diseases. Dalluge also was honored for his research as a collaborating member of the university’s newly created Center for Bioanalysis of Molecular Signaling. The Dalluge mass spectrometry laboratory is part of the Department of Chemistry within the University’s College of Science and Engineering.

Dalluge’s research is focused on the use of leading edge liquid chromatograpy–mass spectrometry (LC–MS) instrumentation for metabolite profiling, biomarker discovery, and advanced assay development, as well as the detailed chemical characterization of biological systems as it relates to function.

Waters Centers of Innovation Program recognizes and supports the efforts of scientists facilitating breakthroughs in health and life science research, food safety, environmental protection, sports medicine, and other areas.

“I am honored to be a part of the Centers of Innovation Program and for what it means to us as we conduct leading-edge research. I regard Waters as more than just an instrument vendor of choice. They are a research partner,” said Dalluge.

Dalluge is one of 13 researchers recognized by Waters Centers of Innovation Program. Others include Jeremy Nicholson, Imperial College (London, England); John Engen, Northeastern University, (Boston, Massachusetts); James Scrivens, University of Warwick (Coventry, UK); David Cowan, Kings College (London, England); Arthur Moseley, Duke University (Durham, North Carolina); Julie Leary, University of California (Davis, California); Albert J. Fornace, Jr., Georgetown Lombardi Comprehensive Cancer Center (Washington, D.C.); Marcos Eberlin, University of Campinas (São Paulo, Brazil); Chang Hsu, Future Fuels Institute (Tallahassee, Florida); Ganesh Anund, National University of Singapore; Konstantinos Petritis, Translational Genomics Research Institute (Phoenix, Arizona); and Vladimir Shulaev, University of North Texas Department of Biological Sciences (Denton, Texas).